Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Pharmaceutical composition capable of reducing blood fat

A composition and blood lipid-lowering technology, which is applied in the direction of drug combinations, pharmaceutical formulas, and plant raw materials, can solve problems such as ineffective effects and long-term effects, and achieve the effects of enhancing immunity, reducing blood lipids, and promoting blood circulation.

Inactive Publication Date: 2018-02-23
黄建文
View PDF2 Cites 2 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0004] In my country, at present, a lot of research work has been done on the prevention and treatment of hyperlipidemia with traditional Chinese medicine. At present, there are many traditional Chinese medicine preparations for lowering blood lipids, such as: Yunnan Huafen Tianqi Oral Liquid, Xinqingning Tablets, Zhikeqing, Shouwu Tablets, Hawthorn Extract Jiangzhi Tablets, Jiangzhi Fitness Tablets, Xinmaitong Tablets, Jiangzhiling Tablets, Dantian Jiangzhi Pills, Ginkgo Leaf Capsules, etc., all have a certain effect on lowering blood lipids, but the effective period is long and the effect is not good. obvious

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0036] The present embodiment provides a blood lipid-lowering pharmaceutical composition, comprising the following components in parts by weight: 25 parts of Bupleurum, 25 parts of Huangshi, 20 parts of mulberry leaves, 15 parts of Pueraria lobata, 15 parts of Poria cocos, 13 parts of Salvia miltiorrhiza, 13 parts of licorice , 8 servings of hanging golden lanterns, 8 servings of radish seeds, and 8 servings of meat hibiscus.

[0037] The above-mentioned blood lipid-lowering pharmaceutical composition is made into granules, and the specific preparation process is as follows:

[0038] (1) mixing the raw materials, then ultrafine pulverizing;

[0039] (2) Add an appropriate amount of water to the above-mentioned superfine powder and knead;

[0040] (3) The granulator granulates the above-mentioned medicine after kneading;

[0041] (4) Dry the above-mentioned granules, granulate, and sub-package to make granules.

Embodiment 2

[0043] The present embodiment provides a blood lipid-lowering pharmaceutical composition, comprising the following components in parts by weight: 20 parts of Bupleurum bupleuri, 30 parts of Huangshi, 10 parts of mulberry leaves, 20 parts of Pueraria lobata, 20 parts of Poria cocos, 10 parts of salvia miltiorrhiza, 10 parts of licorice , 10 servings of hanging golden lanterns, 10 servings of radish seeds, and 5 servings of meat hibiscus.

[0044] The above-mentioned blood lipid-lowering pharmaceutical composition is made into granules, and the specific preparation process is as follows:

[0045] (1) mixing the raw materials, then ultrafine pulverizing;

[0046] (2) Add an appropriate amount of water to the above-mentioned superfine powder and knead;

[0047] (3) The granulator granulates the above-mentioned medicine after kneading;

[0048] (4) Dry the above-mentioned granules, granulate, and sub-package to make granules.

Embodiment 3

[0050] The present embodiment provides a blood lipid-lowering pharmaceutical composition, comprising the following components in parts by weight: 35 parts of Bupleurum bupleuri, 15 parts of Huangshi, 25 parts of mulberry leaves, 10 parts of kudzu root, 10 parts of Poria cocos, 15 parts of salvia miltiorrhiza, 15 parts of licorice , 5 servings of hanging golden lanterns, 50 servings of radish seeds, and 10 servings of meat hibiscus.

[0051] The above-mentioned blood lipid-lowering pharmaceutical composition is made into granules, and the specific preparation process is as follows:

[0052] (1) mixing the raw materials, then ultrafine pulverizing;

[0053](2) Add an appropriate amount of water to the above-mentioned superfine powder and knead;

[0054] (3) The granulator granulates the above-mentioned medicine after kneading;

[0055] (4) Dry the above-mentioned granules, granulate, and sub-package to make granules.

[0056] The blood lipid-lowering pharmaceutical compositio...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention relates to a pharmaceutical composition capable of reducing blood fat. The pharmaceutical composition is prepared from the following raw materials: radix bupleuri, radix astragali, mulberry leaf, roots of kudzu vine, poria cocos, roots of red-rooted salvia, liquorice root, lantern plant calyx, radish seeds and herba cistanches. The pharmaceutical composition has the beneficial effects that: the raw materials are prepared from natural medicines, and the components are compounded, so that the blood fat reducing function of the pharmaceutical composition is greatly improved, the curative effect is quick, the cost is low, and the toxic and side effect is reduced.

Description

technical field [0001] The invention relates to the technical field of traditional Chinese medicines, in particular to a pharmaceutical composition capable of reducing the blood lipid content of a human body. Background technique [0002] With the acceleration of the industrialization process, people's material life has been greatly improved. While enjoying the material civilization brought about by economic development, human beings feel more and more that the doom brought by material enjoyment is approaching. Hyperlipidemia caused by one's own bad life behavior has become the main threat factor of modern diseases. Atherosclerosis caused by hyperlipidemia is the main cause of coronary heart disease, hypertension and cardiovascular and cerebrovascular diseases. [0003] At present, the treatment of hyperlipidemia is mainly to take western medicine. There are two main types of western medicine lipid-lowering drugs, statins mainly for lowering total cholesterol and low-densit...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): A61K36/81A61P3/06A61P9/10
CPCA61K36/076A61K36/233A61K36/31A61K36/481A61K36/484A61K36/488A61K36/537A61K36/605A61K36/65A61K36/71A61K36/81A61K2300/00
Inventor 黄建文
Owner 黄建文
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com